Skip to main content

Dysphagia

3
Pipeline Programs
10
Companies
13
Clinical Trials
6 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

9 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Injection laryngoplastyPhase 41 trial
Active Trials
NCT01507207Completed50Est. May 2015
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
3 programs
1
MethylprednisolonePhase 21 trial
3-Screenings ProtocolN/A1 trial
FEESN/A1 trial
Active Trials
NCT05108896Recruiting855Est. Dec 2025
NCT02363686Completed248Est. Nov 2020
NCT06670521Recruiting80Est. May 2027
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
1
In-person sEMG-biofeedbackPhase 21 trial
Active Trials
NCT06638944Recruiting120Est. Apr 2029
Phagenesis
PhagenesisUK - Manchester
2 programs
1. Phagenyx® System Group PatientsN/A1 trial
Pharyngeal Electrical StimulationN/A1 trial
Active Trials
NCT06866418Recruiting600Est. Sep 2036
NCT03840395Recruiting360Est. Dec 2025
Knight Therapeutics
Knight TherapeuticsQC - Montréal
2 programs
Cytology Specimen Collection ProcedureN/A1 trial
DexamethasoneN/A1 trial
Active Trials
NCT02100189Completed50Est. Dec 2015
NCT01748942Completed76Est. Mar 2017
Boston Scientific
Boston ScientificCA - Valencia
1 program
Dilation 10 secN/A1 trial
Active Trials
NCT01738997Completed20
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Esophageal string testN/A1 trial
Active Trials
NCT07027826Recruiting70Est. Aug 2027
Alliance Pharmaceuticals
1 program
repetitive magnetic stimulationN/A1 trial
Active Trials
NCT03253354Completed12Est. Aug 2021
Swedish Orphan Biovitrum
1 program
PaliferminPHASE_21 trial
Active Trials
NCT00094861Completed100Est. Jan 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Oregon TherapeuticsInjection laryngoplasty
Purdue PharmaIn-person sEMG-biofeedback
Colorado TherapeuticsMethylprednisolone
Swedish Orphan BiovitrumPalifermin
Allergy TherapeuticsEsophageal string test
Phagenesis1. Phagenyx® System Group Patients
Colorado Therapeutics3-Screenings Protocol
PhagenesisPharyngeal Electrical Stimulation
Alliance Pharmaceuticalsrepetitive magnetic stimulation
Knight TherapeuticsCytology Specimen Collection Procedure
Knight TherapeuticsDexamethasone
Colorado TherapeuticsFEES
Boston ScientificDilation 10 sec

Clinical Trials (13)

Total enrollment: 2,641 patients across 13 trials

NCT01507207Oregon TherapeuticsInjection laryngoplasty

Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft

Start: Jan 2012Est. completion: May 201550 patients
Phase 4Completed
NCT06638944Purdue PharmaIn-person sEMG-biofeedback

Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease

Start: Jul 2025Est. completion: Apr 2029120 patients
Phase 2Recruiting
NCT06670521Colorado TherapeuticsMethylprednisolone

Corticosteroids for Post-Extubation Dysphagia

Start: Nov 2024Est. completion: May 202780 patients
Phase 2Recruiting
NCT00094861Swedish Orphan BiovitrumPalifermin

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Start: Jan 2005Est. completion: Jan 2014100 patients
Phase 2Completed
NCT07027826Allergy TherapeuticsEsophageal string test

The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States

Start: May 2026Est. completion: Aug 202770 patients
N/ARecruiting
NCT06866418Phagenesis1. Phagenyx® System Group Patients

Phagenyx® Registry Study

Start: Sep 2025Est. completion: Sep 2036600 patients
N/ARecruiting
NCT05108896Colorado Therapeutics3-Screenings Protocol

Aspiration in Acute Respiratory Failure Survivors 2

Start: Dec 2021Est. completion: Dec 2025855 patients
N/ARecruiting
NCT03840395PhagenesisPharyngeal Electrical Stimulation

The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy

Start: Jun 2019Est. completion: Dec 2025360 patients
N/ARecruiting
NCT03253354Alliance Pharmaceuticalsrepetitive magnetic stimulation

Neurostimulation for Dysphagia in Parkinson's Disease

Start: Aug 2017Est. completion: Aug 202112 patients
N/ACompleted
NCT02100189Knight TherapeuticsCytology Specimen Collection Procedure

Esophageal Cytology With FISH in Detecting Esophageal Cancer

Start: Feb 2014Est. completion: Dec 201550 patients
N/ACompleted
NCT01748942Knight TherapeuticsDexamethasone

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

Start: Dec 2012Est. completion: Mar 201776 patients
N/ACompleted
NCT02363686Colorado TherapeuticsFEES

Aspiration in Acute Respiratory Failure Survivors

Start: Feb 2012Est. completion: Nov 2020248 patients
N/ACompleted
NCT01738997Boston ScientificDilation 10 sec

Endoscopical Dilation of Benign Esophageal Strictures

Start: Dec 200320 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 actively recruiting trials targeting 2,641 patients
10 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.